WorldQuant Millennium Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.9M Buy
+191,790
New +$20.7M 0.11% 173
2025
Q4
– Sell
-143,431
Closed -$3.7M – 622
2025
Q3
$3.7M Sell
143,431
-697,164
-83% -$19.4M 0.02% 318
2025
Q2
$23.2M Buy
+840,595
New +$22.1M 0.12% 190
2022
Q1
– Sell
-32,002
Closed -$8.13M – 336
2021
Q4
$8.13M Sell
32,002
-31,142
-49% -$9.11M 0.16% 178
2021
Q3
$24.3M Sell
63,144
-17,412
-22% -$6.42M 0.53% 50
2021
Q2
$18.9M Buy
+80,556
New +$14.4M 0.42% 82
2021
Q1
– Sell
-92,347
Closed -$9.6M – 356
2020
Q4
$9.6M Buy
92,347
+71,141
+335% +$7.2M 0.21% 163
2020
Q3
$1.5M Buy
21,206
+8,537
+67% +$595K 0.04% 294
2020
Q2
$813K Buy
+12,669
New +$694K 0.02% 320

Other funds holding MRNA

WorldQuant Millennium Advisors's MRNA Position: Q3 2026 in Review

WorldQuant Millennium Advisors opened a new position in Moderna (MRNA) in Q3 2026: 191,790 shares worth $36.9M. The stake represents 0.11% of the portfolio and ranks #173 among its holdings. This is a return to the name: WorldQuant Millennium Advisors previously reported a position in MRNA as recently as Q3 2025.

WorldQuant Millennium Advisors first reported a position in MRNA in Q2 2020 and has held it in 9 quarters since. 1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • WorldQuant Millennium Advisors held 191,790 shares of Moderna worth $36.9M as of Q3 2026.
  • Moderna was a new WorldQuant Millennium Advisors position in Q3 2026.
  • Moderna made up 0.11% of WorldQuant Millennium Advisors's portfolio in Q3 2026, its #173 holding.
  • WorldQuant Millennium Advisors first reported a position in Moderna in Q2 2020 and has held it in 9 quarters since.
  • 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.